Life Science Connect (LSC), a leading US-based life sciences media company and portfolio business of Latticework Capital Management and Edgehill Management, has announced the acquisition of PharmaSource and CDMO Live from Life Science Networks. The strategic deal strengthens LSC’s position in the global biopharma outsourcing sector by adding two highly respected industry brands to its expanding portfolio.
The acquisition brings PharmaSource and CDMO Live under the Life Science Connect umbrella, enhancing the company’s ability to serve professionals across the biopharmaceutical outsourcing ecosystem. Both brands are widely recognized for delivering industry insights, networking opportunities, and events that connect pharmaceutical companies with contract development and manufacturing organizations (CDMOs).
By integrating these established platforms, Life Science Connect aims to expand its media, events, and digital engagement capabilities while providing greater value to pharmaceutical manufacturers, biotechnology companies, contract service providers, and industry suppliers. The acquisition also reinforces LSC’s commitment to supporting innovation, collaboration, and knowledge sharing throughout the global life sciences industry.
PharmaSource has earned a strong reputation for connecting biopharma companies with outsourcing partners through market intelligence, educational content, and business networking opportunities. Meanwhile, CDMO Live has become a leading event platform focused on the rapidly growing contract development and manufacturing sector, bringing together key decision-makers, service providers, and technology experts.
According to Life Science Connect, the addition of these brands aligns with its long-term strategy of building the world’s leading biopharma outsourcing media and events platform. The expanded portfolio is expected to create new opportunities for industry professionals through enhanced content, strategic partnerships, networking events, and educational initiatives.
The acquisition also reflects the continued growth of the global biopharmaceutical outsourcing market, where increasing demand for specialized manufacturing, research, and development services is driving collaboration between pharmaceutical companies and contract service providers. By combining the strengths of PharmaSource, CDMO Live, and Life Science Connect, the organization is well-positioned to support the evolving needs of the life sciences community.
With this strategic expansion, Life Science Connect further reinforces its leadership in delivering trusted industry news, professional networking opportunities, and high-value events that connect stakeholders across the global biopharmaceutical outsourcing landscape.
